Detail Information of Genetic Polymorphisms
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0322 Transporter Info | ||||
Gene Name | SLC37A1 | ||||
Protein Name | Glycerol-3-phosphate permease | ||||
Gene ID | |||||
UniProt ID | |||||
Genetic Polymorphisms of DT (GPD) | |||||
Genetic Polymorphism | rs35112095 | ||||
Site of GPD | chr21:42569923 (GRCh38.p12) | ||||
GPD Type | SNP | ||||
Allele(s) in dbSNP | G>A | ||||
Minor Allele Frequency | G=0.9880/1955 (Global) | ||||
Allele G | Click to Show/Hide the Full List of Affected Drugs: 2 Drugs in Total | ||||
Anastrozole | N.A. | Fractures, Bone | Allele G is not associated with risk of Fractures, Bone when exposed to anastrozole and exemestane in women with Breast Neoplasms as compared to allele A. | [ 1] | |
Exemestane | N.A. | Fractures, Bone | Allele G is not associated with risk of Fractures, Bone when exposed to anastrozole and exemestane in women with Breast Neoplasms as compared to allele A. | [ 1] | |
References | |||||
1 | Aromatase inhibitor-associated bone fractures: a case-cohort GWAS and functional genomics. Mol Endocrinol. 2014 Oct;28(10):1740-51. |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.